Technical Analysis for KYMR - Kymera Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 37.21 | 2.34% | 0.85 |
KYMR closed down 1.33 percent on Monday, January 30, 2023, on 55 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Boomer Buy Setup | Bullish Swing Setup | 2.34% | |
| NR7 | Range Contraction | 2.34% | |
| Inside Day | Range Contraction | 2.34% | |
| Wide Bands | Range Expansion | 2.34% | |
| Overbought Stochastic | Strength | 2.34% | |
| Gapped Down | Weakness | 2.34% | |
| Inside Day | Range Contraction | 0.98% | |
| Wide Bands | Range Expansion | 0.98% | |
| Overbought Stochastic | Strength | 0.98% | |
| Outside Day | Range Expansion | 4.88% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 5 hours ago |
| Up 3% | about 6 hours ago |
| 10 DMA Support | about 6 hours ago |
| Boomer Buy Entry | about 6 hours ago |
| Rose Above Previous Day's High | about 6 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/22/2023
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Immunology Solid Tumors Immune System Autoimmune Disease Rheumatoid Arthritis Autoimmunity Hematologic Malignancies Dermatitis Atopic Dermatitis Hidradenitis Suppurativa
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Immunology Solid Tumors Immune System Autoimmune Disease Rheumatoid Arthritis Autoimmunity Hematologic Malignancies Dermatitis Atopic Dermatitis Hidradenitis Suppurativa
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 46.18 |
| 52 Week Low | 13.15 |
| Average Volume | 785,308 |
| 200-Day Moving Average | 25.62 |
| 50-Day Moving Average | 29.37 |
| 20-Day Moving Average | 31.97 |
| 10-Day Moving Average | 35.57 |
| Average True Range | 2.15 |
| RSI | 64.66 |
| ADX | 33.65 |
| +DI | 27.36 |
| -DI | 11.88 |
| Chandelier Exit (Long, 3 ATRs) | 31.26 |
| Chandelier Exit (Short, 3 ATRs) | 30.49 |
| Upper Bollinger Bands | 40.70 |
| Lower Bollinger Band | 23.24 |
| Percent B (%b) | 0.75 |
| BandWidth | 54.63 |
| MACD Line | 2.44 |
| MACD Signal Line | 2.05 |
| MACD Histogram | 0.3907 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 38.05 | ||||
| Resistance 3 (R3) | 37.95 | 37.28 | 37.77 | ||
| Resistance 2 (R2) | 37.28 | 36.85 | 37.33 | 37.67 | |
| Resistance 1 (R1) | 36.82 | 36.59 | 37.05 | 36.92 | 37.58 |
| Pivot Point | 36.16 | 36.16 | 36.27 | 36.21 | 36.16 |
| Support 1 (S1) | 35.70 | 35.73 | 35.93 | 35.80 | 35.14 |
| Support 2 (S2) | 35.03 | 35.46 | 35.08 | 35.05 | |
| Support 3 (S3) | 34.57 | 35.03 | 34.95 | ||
| Support 4 (S4) | 34.67 |
